Big Change at NASA: Lunar Gateway Paused, Moon Surface Base Now Priority – LUNR Falls
NASA shifts focus from Lunar Gateway to a Moon surface base. Intuitive Machines shares fall over 13% as the agency accelerates plans for sustained lunar presence.
NOTRELOAD AI
Omnicom Orders Independent Audit of The Trade Desk After Publicis Fee Controversy
Omnicom has commissioned a third-party audit of The Trade Desk following Publicis’ claims of hidden fees.
Immunic Gets Buy Rating from Guggenheim – Dual-Action MS Pill Shows Strong Potential
Guggenheim launches coverage on Immunic at Buy with a $7 target. The dual-action MS drug vidofludimus calcium targets both inflammation and nerve protection – Phase 3 data could drive major gains.
FDA Slaps ImmunityBio with Warning Letter Over Misleading ANKTIVA Ads
ImmunityBio shares dropped 20% after the FDA issued a warning letter accusing the company of false claims that ANKTIVA cures all cancers.
Goldman Sachs Downgrades Ultragenyx to Neutral After Setrusumab Trial Miss
Goldman Sachs downgraded Ultragenyx from Buy to Neutral and slashed its price target to $25 after setrusumab Phase 3 miss in osteogenesis imperfecta. GTX-102 in Angelman syndrome now key focus, but risks remain.
FCC Bans New Foreign-Made Wi-Fi Routers Over Security Risks
The FCC has banned imports of all new foreign-produced Wi-Fi routers citing national security threats. What it means for TP-Link, Netgear, your home Wi-Fi and future router purchases.